Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Further study of chromosome 7p22 to identify the molecular basis of familial hyperaldosteronism type II

Journal of Human Hypertension volume 25, pages 560–564 (2011)Cite this article

Subjects

Abstract

Familial hyperaldosteronism type II (FH-II) is an inherited form of hyperaldosteronism associated with hypertension in most patients. The mutations that cause FH-II are unknown, but linkage analysis has mapped them to chromosome 7p22. As FH-II is clinically indistinguishable from sporadic primary aldosteronism, a common and treatable condition, unravelling the cause of FH-II has important implications for these sporadic cases. To investigate whether FH-II is caused by large deletions or insertions, we examined the virtual karyotype of four pairs of affected and unaffected individuals using high-density bead chips. We also sequenced the coding regions of five 7p22 candidate genes that were prioritized because of their putative role in cell growth. We found no evidence of single-nucleotide polymorphism (SNP) copy number variation between pairs, and from the widest gap on the chip, chromosome 7p22 deletions or insertions exceeding ∼50 kb in these pedigrees can be excluded. We found 15 SNPs (two of which were novel), but none of them were non-synonymous and segregated with the disease in the FH-II pedigrees. We have been able to exclude large genomic deletions or insertions at 7p22 and refine the candidate gene list for this locus, but the mutations causing FH-II remain elusive.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellini A . Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens Res 2007; 30 (2): 111–117.

    Article  Google Scholar 

  2. Torpy DJ, Gordon RD, Lin JP, Huggard PR, Taymans SE, Stowasser M et al. Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene. J Clin Endocrinol Metab 1998; 83 (9): 3214–3218.

    CAS  PubMed  Google Scholar 

  3. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Finn WL, Krek AL . Clinical and pathological diversity of primary aldosteronism, including a new familial variety. Clin Exp Pharmacol Physiol 1991; 18 (5): 283–286.

    Article  CAS  Google Scholar 

  4. Lafferty AR, Torpy DJ, Stowasser M, Taymans SE, Lin JP, Huggard P et al. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet 2000; 37 (11): 831–835.

    Article  CAS  Google Scholar 

  5. So A, Duffy DL, Gordon RD, Jeske YW, Lin-Su K, New MI et al. Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. J Hypertens 2005; 23 (8): 1477–1484.

    Article  CAS  Google Scholar 

  6. Elphinstone MS, Gordon RD, So A, Jeske YW, Stratakis CA, Stowasser M . Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: no evidence for mutations in familial hyperaldosteronism type II in a large affected kindred. Clin Endocrinol (Oxf) 2004; 61 (6): 716–723.

    Article  CAS  Google Scholar 

  7. Jeske YW, So A, Kelemen L, Sukor N, Willys C, Bulmer B et al. Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II. Clin Exp Pharmacol Physiol 2008; 35 (4): 380–385.

    Article  CAS  Google Scholar 

  8. Newton-Cheh C, Guo CY, Gona P, Larson MG, Benjamin EJ, Wang TJ et al. Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension 2007; 49 (4): 846–856.

    Article  CAS  Google Scholar 

  9. Huang JT, Lee V . Identification and characterization of a novel human FOXK1 gene in silico. Int J Oncol 2004; 25 (3): 751–757.

    CAS  PubMed  Google Scholar 

  10. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD et al. Genes that mediate breast cancer metastasis to lung. Nature 2005; 436 (7050): 518–524.

    Article  CAS  Google Scholar 

  11. Fearns C, Pan Q, Mathison JC, Chuang TH . Triad3A regulates ubiquitination and proteasomal degradation of RIP1 following disruption of Hsp90 binding. J Biol Chem 2006; 281 (45): 34592–34600.

    Article  CAS  Google Scholar 

  12. Lu L, Han AP, Chen JJ . Translation initiation control by heme-regulated eukaryotic initiation factor 2alpha kinase in erythroid cells under cytoplasmic stresses. Mol Cell Biol 2001; 21 (23): 7971–7980.

    Article  CAS  Google Scholar 

  13. Michaelson D, Abidi W, Guardavaccaro D, Zhou M, Ahearn I, Pagano M et al. Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division. J Cell Biol 2008; 181 (3): 485–496.

    Article  CAS  Google Scholar 

  14. Rozen S, Skaletsky H . Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365–386.

    CAS  PubMed  Google Scholar 

  15. Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC, Nazareth L et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med 2010; 362 (13): 1181–1191.

    Article  CAS  Google Scholar 

  16. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 2010; 42 (1): 30–35.

    Article  CAS  Google Scholar 

  17. Dreyer SD, Zhou G, Baldini A, Winterpacht A, Zabel B, Cole W et al. Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet 1998; 19 (1): 47–50.

    Article  CAS  Google Scholar 

  18. Hall TA . BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999; 41: 95–98.

    CAS  Google Scholar 

  19. International HapMap Consortium. The International HapMap Project. Nature 2003; 426 (6968): 789–796.

    Article  Google Scholar 

  20. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293 (5532): 1107–1112.

    Article  CAS  Google Scholar 

  21. Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NS et al. The human gene mutation database: 2008 update. Genome Med 2009; 1 (1): 13.1–13.6.

    Article  Google Scholar 

  22. Hoischen A, van Bon BW, Gilissen C, Arts P, van Lier B, Steehouwer M et al. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat Genet 2010; 42 (6): 483–485.

    Article  CAS  Google Scholar 

  23. Nikopoulos K, Gilissen C, Hoischen A, van Nouhuys CE, Boonstra FN, Blokland EA et al. Next-generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy. Am J Hum Genet 2010; 86 (2): 240–247.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was funded by the British Heart Foundation (PG 08/081/25727). We are grateful to the Cambridge Centre of Microarray Resources for performing the microarray work.

Author information

Authors and Affiliations

  1. Department of Medicine, Clinical Pharmacology Unit, University of Cambridge, Cambridge, UK

    K J Carss & K M O'Shaughnessy

  2. University of Queensland Endocrine Hypertension Research Centre, Brisbane, Australia

    M Stowasser & R D Gordon

Authors
  1. K J Carss
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Stowasser
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R D Gordon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K M O'Shaughnessy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K M O'Shaughnessy.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Journal of Human Hypertension website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carss, K., Stowasser, M., Gordon, R. et al. Further study of chromosome 7p22 to identify the molecular basis of familial hyperaldosteronism type II. J Hum Hypertens 25, 560–564 (2011). https://doi.org/10.1038/jhh.2010.93

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2010.93

Keywords

This article is cited by

Search

Advanced search

Quick links